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Background: In the present study, we determined the effects of HX108-CS (mixed extract of Schisandra chinensis
and Chaenomeles sinensis) supplementation on lactate accumulation and endurance capacity. Furthermore, we
examined CK (creatine kinase), LDH (lactate dehydrogenase) activity to determine whether the HX108-CS affected
markers of skeletal muscle injury in vivo and in vitro.
Methods: Exercise capacity was measured by an exhaustive swimming test using ICR mice divided into four
groups; one group received distilled water (DW) (Control group, n = 10), and the other groups received three
different dosages of HX108-CS (10, 50 and 100 mg/kg, n = 10 per group) solution in water orally. Then, for the
time-dependent measurements of blood lactate, CK, and LDH, Sprague–Dawley rats were divided into two groups;
one received DW (Control group, n = 10), and the other group received HX108-CS (100 mg/kg, n = 10) solution
in the same way as mice. Before the exercise test, the animals were given either DW or HX108-CS for 2 weeks.
High-intensity treadmill exercise was performed for 30 minutes. Blood samples were collected and analyzed during
and after exercise. For the in vitro experiment, C2C12 cells were treated with HX108-CS to examine its effect on
lactate production, CK, and LDH activity.
Results: Blood lactate concentration was significantly lowered immediately after treadmill exercise in HX108-CS
group; however, there were no significant differences in activities of CK and LDH between HX108-CS and control
during treadmill exercise and recovery phase. Furthermore, treatment with 100 mg/kg of HX108-CS led to a
significant increase in the time to exhaustion in swimming test, and concurrently blood lactate concentration was
significantly decreased in 50 and 100 mg/kg treated group. Moreover, our results of in vitro experiment showed
that HX108-CS suppressed lactate production, CK, and LDH activity in a dose-dependent manner.
Conclusions: These results suggest that supplementation with HX108-CS may enhance exercise capacity by
lowering lactate accumulation. This may in part be related to an amelioration of skeletal muscle injury.
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The important of lactate metabolism for endurance
performance has recently been demonstrated. The effect of
lactate production on acidosis has been the topic of recent
researches in the field of exercise physiology. Robergs et al.,
have discussed the creation of H+ ions that occurs during
glycolysis and the production of lactate in circulating level
causes acidosis and in turn that increased lactate production
is one of the several causes of muscle fatigue during intense
exercise [1]. Also, lower blood lactate concentrations at a
given workload improve endurance exercise in various
populations [2,3].
In recent years, various strategies for improvement of
endurance capacity have been adopted in an attempt to
attenuate the muscle damage caused by exercise.
Schisandra chinensis and Chaenomeles sinensis are usually
known as medicinal plants with few side effects such as
toxicity. Schisandra chinensis is a fruit of Schisandra
chinensis Biollon of Schisandraceae. Several studies exist
on the general composition of the extract of the Schisandra
berries and pharmacological experiments have shown its
anti-fatigue effects on small rodents [4]. It has also been
used as a tonic for the treatment of chronic fatigue [5], for
example, in Russia, it is used for anti-fatigue material [6].
On the other hand, Chaenomeles sinensis is a fruit of
Chaenomeles sinensis Koehne of Rosaceae. The fruit of
Chaenomeles sinensis is used in traditional medicine for
the treatment of cough, common cold, and pain in Korea,
Japan and China. It has been reported to contain phenolic
acids, flavonoids, triterpenes, and fragrant compounds.
Furthermore, it has also been known to have anti-oxidant
[7,8] and anti-influenza effect [9].
Several previous studies have shown that the supplemen-
tation of natural substances can decrease the contribution
of exercise-induced physical fatigue and improve the ani-
mal’s physiological capacities. Administration of Schisandra
seed extract (SSE) extended the duration of swimming of
mice [10-12]. These mice that have been treated over 2 to
4 weeks period, showed increased swimming capacity even
after 24 to 48 hours cessation period. In addition, the race
horses treated with Schisandra chinensis were able to
complete the race at an average of 1.8 second faster and
showed lower levels of lactate after exercise, indicating
an improvement in the physical performance of the
horses [13,14].
To the best of our knowledge, there has been no
report to examine the effectiveness of Chaenomeles and
Schisandra on the exercise-induced lactate production
and improvement of endurance performance. Therefore,
we invented HX108-CS which contains both Schisandra
chinensis and Chaenomeles sinensis extracts as active
ingredients for lowering lactate accumulation and for
enhancing athletic capability. In the present study, we
determined the effects of HX108-CS supplement onlactate accumulation during and after high-intensity tread-
mill exercise. Endurance capacity was also evaluated with
exhaustive swimming test. Furthermore, we measured CK
and LDH activities to examine whether the HX108-CS
can decrease muscle injury in vivo and in vitro.
Methods
Animals and surgery
Male ICR mice (4 weeks old, n = 40) and Sprague–Dawley
rats (6 weeks old, n = 20) were obtained from Central Lab
Animal Inc. (Seoul, Korea), kept in air-conditioned room,
and acclimated for at least 7 days. The mice were divided
into four groups; one group received distilled water (DW)
(Control group, n = 10), and the other groups received
three different dosages of HX108-CS (10, 50 and 100 mg/
kg, n = 10 per group) solution in water orally. Then, the rats
were divided into two groups; one received DW (Control
group, n = 10), and the other group received HX108-CS
(100 mg/kg, n = 10) solution in the same way as mice.
Before the exercise test, the animals were given either DW
or HX108-CS for 2 weeks. In the rats, they were anesthe-
tized with zoletil 50 (10 mg/kg, i.p.; Vibac Laboratories,
Carros, France) for surgery. For the blood analysis, a
silicone catheter was inserted into the jugular vein and
fixed by a 35 mm silk thread. The exteriorized distal end of
the catheter was fixed at the animal’s nape as described in a
previous study [15]. Three days after surgery, the rats were
kept individually in their cages until the start of the running
tests for full recovery. All experimental procedures were
approved in accordance with the institutional animal care
and use guidelines of the Animal Experimental Center at
Seoul National University.
The procedures for handling and caring for the
animals were performed in accordance with the NIH
Guide for the Care and Use of Laboratory Animals. The
experimental protocol was approved by the Institutional
Animal Care and Use Committee of Laboratory Animal
Resources at Seoul National University (SNU-100705-6).
Preparation of HX108-CS
Total water-soluble extract of the dried fruits, HX108-CS
was prepared from these hardy kiwifruits. Briefly, the dried
Schisandra chinensis and Chaenomeles sinensis fruits were
mixed at a 2:1 ratio by weight and extracted by boiling in
DW for 3 hours. The extract was filtered with Whatman fil-
ter paper (No. 2, 110 nm), and concentrated using a rotary
evaporator, followed by a freeze-drying process. Powdered
HX108-CS was dissolved in DW at a concentration of
200 mg/ml and stored at −80°C until use.
Cell differentiation and sample treatment (in vitro)
C2C12 cell line (kindly donated by Prof. Kang, Seoul,
Korea) was routinely maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 15% heat
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G and 100 μg/ml streptomycin in a humidified 5% CO2
atmosphere at 37°C. The medium was changed three times
a week. The cells were harvested and reseeded when
reached by 50%.
For lactate measurement, C2C12 cells were seeded on
24-well plates (2.5 x 104 cells/500 μl) in DMEM medium.
C2C12 cells were treated with HX108-CS (250, 500 and
1000 μg/ml) for 30 min before NaN3 (sodium azide) treat-
ment. After 30 min, NaN3 was treated to cells and
incubated for 6.5 hrs. After 7 hrs, supernatant of cells was
harvested and used for lactate measurement. For LDH
and CK activities measurement, C2C12 cells were
differentiated for 5 days. Briefly, C2C12 cells were seeded
on 6-well plates (2 x 105 cells/2 ml) in DMEM medium.
To induce differentiation, the medium was replaced with
DMEM containing 2% horse serum prior to the cells
reaching confluence. The medium was changed every day.
Differentiated C2C12 cells were treated with HX108-CS
(250, 500, and 1,000 μg/ml) and 2, 4-dinitrophenyl (DNP)
for 1 hr. After 1 hr, supernatant of cells was harvested and
used for LDH and CK measurement.
Swim-to-exhaustion exercise test
Each of the mice had a weight attached (10% body weight)
to the tail for the duration of the swim-to-exhaustion exer-
cise. The mice were assessed to be fatigued when they failed
to rise to the surface of the water to breathe within 5 sec.
Swimming time was recorded as minute for each mice.
Blood samples were taken by capillary glass tubes from eye
venous pool of mice when they were no longer able to
continue to swim. Throughout the course of this experi-
ment, one researcher who did not know the grouping of
the mice determined the duration of swimming time to
exhaustion. The swimming exercise was carried out in a
tank (32 × 50 × 35 cm), filled with water to 25 cm depth
and maintained at a temperature of 33 ± 1°C.
Progressive treadmill exercise protocol
Two hours before the experiment, the rats were fasted
by removing chow to minimize the glucose effect from con-
sumption just prior to the measurement. A week before the
day of experiment, all animals were familiarized to the
treadmill, starting with walking on the treadmill (5 m/min)
and then running at 15 m/min, 0% grade for 20 min/day,
5 days/week. The day of the experiment, the rats were
placed on the treadmill at 0% slope and the speed
was gradually increased up to 25 m/min for 30 min.
Measurements of lactate, LDH and CK activity
In vitro study, lactate production, LDH and CK activity
were measured using commercial kit (Lactate assay,
Bioassay systems, USA; LDH assay, Takara, Japan; CK assay,
Bioassay systems, USA). For lactate measurement, theworking reagent (assay buffer, enzyme, NAD, PMS, MTT)
was added into plate and tapped the plate to mix. After
0 min and 20 min, the absorbance at 565 nm was read
using a 96-well plate reader. For LDH assay, the reaction
mixture was added into plate and incubated for 30 min.
After incubation, the absorbance at 490 nm was read
using a 96-well plate reader. For CK assay, the plate
was incubated at 37°C for 10 min. After 10 min and
40 min, the absorbance at 340 nm was read using a
96-well plate reader.
In vivo study, fatigue related parameters were evaluated
as described previously [16] with some modifications.
Lactate concentration (Lactate pro LT-1710, ARKRAY Inc.,
JAPAN) was determined from whole blood samples before,
during (20 and 25 min) and immediately after exercise and
recovery phases (3, 6, 9, 15 and 30 min after exercise) on
the treadmill. On the other hand, LDH and CK levels were
measured from whole blood samples before, immediately
after exercise and recovery phases (15 and 30 min after
exercise). At least 30 μl of blood sample was taken from
the jugular vein catheter to measure blood lactate, LDH
and CK activities. Blood CK and LDH activities were
assayed using commercially available kits (LDH assay,
Takara, Japan; CK assay, Bioassay systems, USA).
Statistical analysis
Data were presented as mean ± S.E.M, and differences
between vales were compared with two-way repeated meas-
ure analysis of variance (ANOVA) followed by Dunnett’s
multiple comparisons with the pre-exercise value as a con-
trol. Differences between groups were tested with unpaired
Student’s t-test by using Origin 8.0. P values less than 0.05,
which were calculated as one-tailed P values, were
considered to be statistically significant.
Results
Effect of HX108-CS on lactate concentration, CK, and LDH
activity after high-intensity treadmill exercise
HX108-CS substantially affects both accumulation and
removal of blood lactate levels during and after high-
intensity treadmill exercise (Figure 1A). The lactate levels
of the resting state were not statistically different between
the control rats (1.1 ± 0.09 mmol/L) and HX108-CS treated
rats (0.98 ± 0.10 mmol/L). However, at immediately after
high-intensity exercise, the maximally elevated blood
lactate concentration was significantly higher in control
group compared HX108-CS group (7.4 ± 0.62 mmol/L vs.
4.4 ± 0.42 mmol/L, p < 0.05). Moreover, in early recovery
phase, HX108-CS facilitated the removal of blood
lactate significantly (p < 0.05) at 3 and 6 min after
treadmill exercise (Figure 1A).
As shown in Figure 1B, both the control and HX108-CS
groups showed a similar pattern of changes in blood
concentration of CK. In both groups, CK increased
Figure 1 Effect of HX108-CS on CK, LDH and lactate after
progressive treadmill exercise. Male SD rats were divided into 2
groups; DW group (DW treated, n = 7), HX108-CS treated group
(100 mg/kg, n = 8). All of rats ran with the same increasing velocity
from 5 m/min up to 25 m/min for 30 minutes at 0% grade (protocol
was illustrated under the graph). Blood samples were collected from
jugular vein before, during and after treadmill exercise. (A) Lactate
concentration in blood, (B) CK activity in blood and (C) LDH activity
in blood. Values are expressed as mean ± SEM. * p < 0.05 significant
difference between DW group vs. HX108-CS treated group.
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values at 15 min recovery phase, then returned to the pre-
exercise level at 30 min recovery. On the other hand, the
peak concentration of blood LDH occurred immediately
after exercise in both groups then gradually decreased
(Figure 1C). However, there were no significant diffe-
rences in the CK and LDH between control group and
HX108-CS treated group.
Effect of HX108-CS on endurance capacity and blood
lactate concentration in swim-to-exhaustion exercise test
We performed swim-to-exhaustion exercise test using the
mice to examine the effect of HX108-CS on endurance
capacity. The significant changes of endurance capacity and
lactate production followed by HX108-CS supplementation
were found in a dose of 100 mg/kg of HX108-CS.
HX108-CS treated animals (100 mg/kg) were statistically
improved the duration of swimming time to exhaustion
by 24.7% compared with control group (Figure 2A,
p < 0.05; swimming duration of 100 mg/kg and
control were 13.58 ± 0.09 and 10.89 ± 0.19, respectively).
Additionally, blood lactate concentration after exhaustive
swimming was significantly decreased at 50 and 100 mg/kg
of HX108-CS (p < 0.05, Figure 2B). These results indicated
that HX108-CS enhanced the endurance capacity with
lessening accumulation of blood lactate.
Effect of HX108-CS on lactate, CK, and LDH activity in
C2C12 cells
HX108-CS was treated with graded concentration (0, 250,
500 and 1000 μg/ml) in C2C12 cells to examine the effect
of HX108-CS on fatigue related parameters including
lactate production, CK, and LDH activity. HX108-CS
suppressed lactate production, CK, and LDH activity in a
dose-dependent manner. As shown in Figure 3A, inhi-
bition of CK activity was fit to the Hill equation, giving an
EC50 of 323.23 ± 6.48 μg/ml. Also, when HX108-CS was
treated with 500 μg/ml, HX108-CS induced inhibition
of LDH activity was evaluated to 43.8 ± 2.5% of the
control value (Figure 3B). Furthermore, HX108-CS
suppressed the production of lactate by 50% in a dose
of 250.23 ± 4.54 μg/ml (Figure 3C).
Discussion
Major findings of current study were that i) oral HX108-CS
(100 mg/kg) supplement significantly lowered the blood
lactate accumulation immediately after high-intensity tread-
mill exercise and early recovery phase; ii) HX108-CS
(100 mg/kg) treated mice improved the duration of swim-
to- exhaustion that was concomitant with the decrease of
lactate concentration; iii) HX108-CS inhibited lactate
release, CK, and LDH activity in a dose-dependent manner
(250, 500, and 1,000 μg/ml) in vitro. The present invention,
named HX108-CS, relates to a composition which contains
Figure 2 Effect of HX108-CS on exercise capacity and lactate
production in swim-to-exhaustion exercise test. Male ICR mice
were divided into 4 groups by different dosage of HX108-CS
(0, 10, 50 and 100 mg/kg) and swim-to-exhaustion exercise test
was performed. (A) Swimming time to exhaustion, (B) Blood lactate
concentration after exhaustive swimming. Values are expressed as
mean ± SEM. * p < 0.05 significant difference between control
(0 mg/kg treatment) group vs. HX108-CS treated group.
Figure 3 Effect of HX108-CS on CK, LDH and lactate in C2C12
cells. C2C12 cells were treated with HX108-CS (250, 500 and
1000 μg/ml) and 2, 4-dinitrophenyl (DNP) and sodium azide (NaN3)
treatment for CK (A) and LDH activity (B), lactate (C) measurement
respectively. Values are expressed as mean ± SEM.
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chinensis extracts was reported as active ingredients for
alleviating muscle fatigue [17], stress behavior [18], and
enhancing exercise capability [10-14]. However, little
is known about the effect of this new composition
(HX108-CS) on lactate production, endurance per-
formance, and the markers of muscle injury after
high-intensity exercise.
We investigated to determine whether supplementa-
tion of HX108-CS suppresses exercise-induced elevation
of lactate level, CK and LDH activities in rats (Figure 1).
Our results showed that the blood lactate concentration
in HX108-CS treated group was significantly lower than
in the control group immediately after exhaustive
exercise (Figure 1A) suggesting that lactate production
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compared with placebo group. Concurrently, removal of
lactate during recovery period was significantly faster in
HX108-CS treated group than placebo group.
On the contrary, CK and LDH activities were not sig-
nificantly changed during and after exhaustive treadmill
exercise and there was no statistical difference between
HX108-CS and control groups. It may partly due to the
dose of HX108-CS. The dose effective to elicit significant
changes in vitro may not be high enough for changing in
circulating levels. It would be worthwhile to try various
high doses of HX108-CS for future study. In previous
studies, serum CK activity has been shown to be elevated
for 24 hours after exercise bouts, with a gradual return to
basal levels in 72–96 hours [19,20], while serum LDH
activity has been shown to be elevated 24 hours after
exercise bouts and is maintained for 48–72 hours [21,22].
However, these previous studies were carried out in
human subjects, and exercise intensity was also supposed
to be higher than present study.
In addition, we conducted another in vivo experiment
using mice to evaluate the effects of HX108-CS supplemen-
tation on endurance capacity using swimming exercise. We
investigated whether or not oral supplementations of
HX108-CS (0, 10, 50 and 100 mg/kg) would extend
swimming time and suppress blood lactate concentration.
Our results showed that duration of swimming time was
prolonged significantly only in 100 mg/kg of HX108-CS
group and swimming-induced lactate concentration was
inhibited by both 50 and 100 mg/kg of HX108-CS groups
(Figure 2). These results indicated that supplementation of
HX108-CS is likely to be related to the improvement
of endurance capacity, and the most effectual dose of
HX108-CS in this regard was 100 mg/kg. To date,
only one study reported different dose (30 mg/kg) of
Schisandra chinensis had significant effect on the endurance
capacity in mice with the measurement of blood lactate
concentration [17]. In this study [17], the increase ratio of
the blood lactate was also significantly lower in dose
of 50 mg/kg of Schisandra chinensis aqueous extract
consistent with the data of swimming endurance test.
Possible explanations why doses were different between our
study and previous study with respect to endurance
capacity and lactate include (i) treatment period
(14 days vs. 28 days), (ii) composition of supplement
(mixed extract treatment vs. Schisandra chinensis only
treatment) (iii) different species of mice (ICR vs.
Kuming), (iv) exercise intensity (different weight bearing;
10% vs. 5% of body mass).
Finally, we investigated the effect of HX108-CS on
lactate production, CK, and LDH activity in vitro using
C2C12 cells (Figure 3). HX108-CS suppressed the CK,
LDH activity and lactate production in a dose-dependent
manner in C2C12 cells. Treatment of intact muscles with2, 4-dinitrophenyl (DNP) has previously been shown to
result in a decline in muscle ATP concentration [23] and
increase of CK activity concentration [24]. Release of CK
from skeletal muscle has long been used as an index of
damage to muscle in both in vitro and in vivo studies. The
CK reaction is of vital importance to skeletal muscle
contraction. This reaction provides the most immediate
means to replenish ATP in the cytosol. In this investiga-
tion, the DNP-induced increases of lactate production,
CK, and LDH activities were inhibited by HX108-CS
treatment (250, 500, and 1,000 μg/ml) in C2C12 cell. The
results of in vitro study suggest that HX108-CS potentially
exerts beneficial effects on muscle fatigue by alleviating
muscle damage.
Conclusions
In conclusion, our data suggest that the composition of the
present invention (HX108-CS) may have beneficial effects
on endurance capacity by lowering lactate accumulation.
This may in part be related to an amelioration of skeletal
muscle injury. Further studies to elucidate the underlying
mechanisms how HX108-CS exerts anti-fatigue effect
will be required. In addition, careful consideration of
clinical trial with human participants will be a subject
of a follow-up study.
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